Condition

Squamous Cell Non Small Cell Lung Cancer

ClinicalTrials.gov condition label

Clinical trials2

Recruiting1

Common interventions5

Lead sponsors shown2

Clinical trials

2 shown

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid TumorsNCT04977453 · 2021-08-02

RECRUITING

MGD019 DART® Protein in Unresectable/Metastatic CancerNCT03761017 · 2018-12-12

COMPLETED

Common interventions

GI-101DRUG1GI-101ADRUG1LenvatinibDRUG1LorigerlimabBIOLOGICAL1Pembrolizumab (KEYTRUDA®)DRUG1

Leading sponsors

GI Innovation, Inc.1MacroGenics1

Trial status mix

COMPLETED1

RECRUITING1

Phase mix

PHASE12

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.